期刊
BIOMEDICINE & PHARMACOTHERAPY
卷 153, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113364
关键词
Thymoquinone; Pancreaticcancer; Chemopreventive; anticanceragent; Apoptosis; Molecularmechanisms; Signalingpathways
资金
- ANID [210012]
- Medical University of Lublin [07/2022]
Thymoquinone has multiple biological activities, including anti-inflammatory, antioxidant, and anticancer effects. It has shown potential as an additional therapeutic agent against pancreatic cancer by altering cell cycle progression, inhibiting cell proliferation, and stimulating apoptosis. Clinical trials are needed to further explore its success in human medicine.
Thymoquinone (TQ) is a secondary metabolite found in abundance in very few plant species including Nigella sativa L., Monarda fistulosa L., Thymus vulgaris L. and Satureja montana L. Preclinical pharmacological studies have shown that TQ has many biological activities, such as anti-inflammatory, antioxidant and anticancer. Both in vivo and in vitro experiments have shown that TQ acts as an antitumor agent by altering cell cycle progression, inhibiting cell proliferation, stimulating apoptosis, inhibiting angiogenesis, reducing metastasis and affecting autophagy. In this comprehensive study, the evidence on the pharmacological potential of TQ on pancreatic cancer is reviewed. The positive results of preclinical studies support the view that TQ can be considered as an additional therapeutic agent against pancreatic cancer. The possibilities of success for this compound in human medicine should be further explored through clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据